Serving as the gold standard in population-based modeling, Certara software transforms modern drug discovery and development through its advanced Simcyp PBPK Simulator. This versatile platform applies seamlessly to small molecules, biologics, and complex generics, empowering researchers to accurately predict first-in-human doses and optimize clinical study designs. By leveraging sophisticated simulation capabilities, teams can efficiently assess drug-drug interactions, evaluate absorption profiles, conduct virtual bioequivalence analyses, and secure label claims without relying solely on traditional clinical studies. Ultimately, Certara helps organizations mitigate compound risks, navigate novel routes of administration, and accelerate safe therapeutics to market.

Join for free to read